Genomic Stratification of Benefit From Short-Term Androgen Deprivation With Dose-Escalated Radiotherapy in Intermediate-Risk Prostate Cancer: An Ancillary Study of NRG/RTOG 0815

Authors

• A Y. Jia
• M Johnson
• J Proudfoot
• E Davicioni
• Z H. Rana
• T M. Seibert
• D E. Spratt
• J Simko
• D E. Citrin
• Daniel J. Krauss, Corewell Health East

Document Type

Conference Proceeding

Publication Date

9-2026

Publication Title

International Journal of Radiation Oncology, Biology, Physics

Volume

126

Issue

1 Suppl

First Page

S144

Last Page

S145

Recommended Citation

Jia AY, Johnson M, Proudfoot J, Davicioni E, Rana ZH, Seibert TM, et al. [Krauss DJ]. Genomic stratification of benefit from short-term androgen deprivation with dose-escalated radiotherapy in intermediate-risk prostate cancer: an ancillary study of NRG/RTOG 0815. Int J Radiat Oncol Biol Phys. 2026 Sep;126(1 Suppl):S144-S145. doi:10.1016/j.ijrobp.2026.06.224

Comments

American Society for Radiation Oncology (ASTRO) 68th Annual Meeting, September 26-30, 2026, Boston, MA

DOI

10.1016/j.ijrobp.2026.06.224